European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Clinical trial NCT02495974 · COMPLETED
Trial details
- NCT number
- NCT02495974
- Sponsor
- Astellas Pharma Europe Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-09-08
- Primary completion
- 2019-02-08
- Enrollment
- 1763
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.